UBS Group
WDNA icon

UBS Group’s WisdomTree BioRevolution Fund WDNA Stock Holding History

UBS Group’s Portfolio WDNA Stock Details WDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-33
Closed -$524 – 11228
2025
Q3 		$524 Buy
+33
New +$476 ﹤0.01% 9639
2024
Q3 		– Sell
-37
Closed -$584 – 10115
2024
Q2 		$584 Sell
37
-62
-63% -$994 ﹤0.01% 8856
2024
Q1 		$1.7K Buy
+99
New +$1.65K ﹤0.01% 8072
2023
Q4 		– Sell
-44
Closed -$666 – 9941
2023
Q3 		$666 Buy
+44
New +$742 ﹤0.01% 8345
2023
Q2 		– Sell
-630
Closed -$10.8K – 9720
2023
Q1 		$10.8K Buy
630
+82
+15% +$1.44K ﹤0.01% 7549
2022
Q4 		$9.51K Buy
548
+73
+15% +$1.29K ﹤0.01% 8641
2022
Q3 		$8K Buy
+475
New +$8.78K ﹤0.01% 8756
2022
Q2 		– Sell
-893
Closed -$18K – 11004
2022
Q1 		$18K Buy
893
+156
+21% +$3.14K ﹤0.01% 7590
2021
Q4 		$17K Buy
737
+637
+637% +$15.7K ﹤0.01% 8085
2021
Q3 		$3K Buy
+100
New +$2.64K ﹤0.01% 8847

Other funds holding WDNA

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group's WDNA Position: Q4 2025 in Review

UBS Group sold out of WisdomTree BioRevolution Fund (WDNA) in Q4 2025, closing a stake of 33 shares — an estimated $524 sold.

UBS Group first reported a position in WDNA in Q3 2021 and held it in 10 quarters. The position peaked at $18K in Q1 2022. 3 funds tracked by Wall St. Rank hold WDNA as of Q4 2025.

  • UBS Group reported no remaining WisdomTree BioRevolution Fund position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 33 WisdomTree BioRevolution Fund shares in Q4 2025, an estimated $524.
  • UBS Group first reported a position in WisdomTree BioRevolution Fund in Q3 2021 and held it in 10 quarters.
  • UBS Group's WisdomTree BioRevolution Fund position peaked at $18K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.